Volume | 3,912 |
|
|||||
Noticias | - | ||||||
Máximo del Dia | 3.085 | Mínimo Máximo |
|||||
Minimo del Dia | 2.99 |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Anebulo Pharmaceuticals Inc | ANEB | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
2.99 | 2.99 | 3.085 | 2.87 | 2.78 |
Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
---|---|---|---|---|---|
39 | 3,912 | US$ 3.01 | US$ 11,774 | - | 1.62 - 4.05 |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
15:00:00 | 210 | US$ 2.87 | USD |
Información Financiera Anebulo Pharmaceuticals Inc ANEB
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
79.87M | 25.93M | - | 0 | -11.73M | -0.45 | - |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre Anebulo Pharmaceuticals Inc ANEB
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
13/2/2024 | 15:30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
13/2/2024 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report |
13/2/2024 | 15:05 | Business Wire | Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year.. |
21/11/2023 | 15:01 | Edgar (US Regulatory) | Form 8-K - Current report |
14/11/2023 | 15:05 | Business Wire | Anebulo Pharmaceuticals Reports First Quarter Fiscal Year.. |
30/10/2023 | 08:31 | Edgar (US Regulatory) | Form ARS - Annual Report to Security Holders |
30/10/2023 | 08:22 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
19/10/2023 | 16:18 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements |
06/10/2023 | 15:10 | Edgar (US Regulatory) | Form 8-K - Current report |
06/10/2023 | 15:06 | Business Wire | Anebulo Pharmaceuticals Announces New CEO |
02/10/2023 | 16:01 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
22/9/2023 | 15:05 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
Histórico de Datos ANEB
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.43 | 3.085 | 2.40 | 2.66 | 4,233 | 0.44 | 18.11% |
1 Month | 2.85 | 3.25 | 2.40 | 2.63 | 5,403 | 0.02 | 0.70% |
3 Months | 2.35 | 3.30 | 2.30 | 2.62 | 5,187 | 0.52 | 22.13% |
6 Months | 3.07 | 3.6099 | 1.62 | 2.38 | 13,916 | -0.20 | -6.51% |
1 Year | 2.87 | 4.05 | 1.62 | 2.49 | 9,557 | 0.00 | 0.00% |
3 Years | 7.38 | 9.33 | 1.62 | 4.64 | 10,631 | -4.51 | -61.11% |
5 Years | 7.38 | 9.33 | 1.62 | 4.64 | 10,631 | -4.51 | -61.11% |